(RTTNews) - MorphoSys AG (MOR) and Incyte Corp. (INCY) said that their joint collaboration and license agreement for the further development and global commercialization of MorphoSys' investigational compound tafasitamab has received antitrust clearance and becomes effective tod
(RTTNews) - The Japanese stock market opened lower on Wednesday and the safe-haven yen strengthened following the negative cues overnight from Wall Street after a surprise rate cut by the Federal Reserve. However, the market has recovered and is now modestly higher.
What happened
Shares of Cisco Systems (NASDAQ: CSCO) fell 13.1% in February, according to data from S&P Global Market Intelligence . The stock fell after the company reported second-quarter earnings and moved lower later in the month as concerns about the impact of the no
Moderna (NASDAQ: MRNA) announced after the closing bell on Tuesday that it had finished enrollment for a mid-stage clinical study concerning one of its mRNA-based vaccines. The treatment in question, mRNA-1647, seeks to treat cytomegalovirus (CMV), a major cause of birth defects
Yext (YEXT) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.
Benefitfocus (BNFT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.
Cardlytics, Inc. (CDLX) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to loss of $0.06 per share a year ago. These figures are adjusted for non-recurring items.
AeroVironment (AVAV) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.17. This compares to earnings of $0.35 per share a year ago. These figures are adjusted for non-recurring items.
What happened
Shares of cancer diagnostics company Exact Sciences (NASDAQ: EXAS) dropped 13.3% in January, according to the latest report from S&P Global Market Intelligence. That move erased 2019 gains and reduced the stock price to new 52-week lows.
What happened
Shares of Mattel (NASDAQ: MAT) fell 19.4% in February, according to data from S&P Global Market Intelligence, on concerns that factory disruptions resulting from the coronavirus may weigh on earnings in the coming quarters.
Inovio Pharmaceuticals (NASDAQ: INO) is making progress in its efforts to develop a vaccine for SARS-CoV-2, the coronavirus that causes COVID-19. Shares of the biotech company closed up 70% on Tuesday on word that it could start a clinical trial next month.
What happened
Shares of Beyond Meat (NASDAQ: BYND) fell 18.8% in February, according to data provided by S&P Global Market Intelligence, after the maker of plant-based meat alternatives reported a loss for the fourth quarter and announced a full-year 2020 adjusted EBITDA f